# Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes

> **NCT00007904** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 16 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** paclitaxel
- **DRUG:** tamoxifen citrate
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00007904
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2006-06
- **Final completion:** 2012-09
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00007904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00007904, "Adjuvant Stage 2-3A Breast Cancer With Positive Lymph Nodes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00007904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*